2018
DOI: 10.1055/s-0038-1660474
|View full text |Cite
|
Sign up to set email alerts
|

Surgical Management of Pulmonary Mycobacterial Disease

Abstract: There is renewed interest in the use of adjuvant surgical resection in the treatment of pulmonary mycobacterial disease. For pulmonary , the emergence of significant drug resistance has led clinicians to reconsider surgery in select cases, where a clear benefit in bacterial conversion and cure has been noted. Less data exist for the use of anatomic resection in the setting of pulmonary nontuberculous mycobacterial disease, although multiple reports have supported the use of surgery in select cases. Resection i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0
1

Year Published

2018
2018
2022
2022

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 41 publications
0
1
0
1
Order By: Relevance
“…culture conversion rate vs. medical therapy alone [34]. We have previously summarized recommended initial testing treatment regimens, clinical monitoring, and adverse effects to be expected in transplant patients [35 & ]; here, we focus on newer agents against MABC and MAC.…”
Section: Treatmentmentioning
confidence: 99%
“…culture conversion rate vs. medical therapy alone [34]. We have previously summarized recommended initial testing treatment regimens, clinical monitoring, and adverse effects to be expected in transplant patients [35 & ]; here, we focus on newer agents against MABC and MAC.…”
Section: Treatmentmentioning
confidence: 99%
“…Другим важным прогностическим фактором исхода хирургического лечения ТБ является осложнённое течение легочных форм ТБ (наличие кровохарканья, эпизоды лёгочного кровотечения, эмпиемы и др.) [10,11,15].…”
unclassified